Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,131 | 218,044 | 118,615 | 155,088 | 104,953 |
| Marketable Securities | 1,220,322 | 1,118,171 | 987,440 | 913,580 | 852,569 |
| Other current assets | 0 | 0 | 0 | 357 | 0 |
| TOTAL | $1,325,162 | $1,372,319 | $1,138,526 | $1,114,600 | $988,436 |
| Non-Current Assets | |||||
| PPE Net | 42,117 | 44,087 | 41,692 | 38,703 | 37,679 |
| Investments And Advances | 0 | 0 | 0 | 94,220 | 250,268 |
| Other Non-Current Assets | 42,065 | 43,836 | 47,388 | 44,939 | 44,475 |
| TOTAL | $84,182 | $87,923 | $89,080 | $177,862 | $332,422 |
| Total Assets | $1,409,344 | $1,460,242 | $1,227,606 | $1,292,462 | $1,320,858 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,215 | 2,790 | 7,539 | 7,116 | 3,358 |
| Accrued Expenses | 76,666 | 66,691 | 40,828 | 34,358 | 33,039 |
| Other current liabilities | 305,660 | 294,441 | 305,235 | 300,815 | 299,184 |
| TOTAL | $391,080 | $363,922 | $360,670 | $348,160 | $341,240 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 51,558 | 53,890 | 55,633 | 59,854 | 61,691 |
| TOTAL | $51,558 | $53,890 | $55,633 | $59,854 | $61,691 |
| Total Liabilities | $442,638 | $417,812 | $416,303 | $408,014 | $402,931 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 136,889 | 136,678 | 135,814 | 123,348 | 122,948 |
| Common Shares | 1,694 | 1,686 | 1,564 | 1,558 | 1,554 |
| Retained earnings | -1,080,768 | -970,987 | -872,309 | -769,010 | -710,216 |
| Other shareholders' equity | -2,517 | -6,886 | -11,853 | -12,274 | -9,251 |
| TOTAL | $966,706 | $1,042,430 | $811,303 | $884,448 | $917,927 |
| Total Liabilities And Equity | $1,409,344 | $1,460,242 | $1,227,606 | $1,292,462 | $1,320,858 |